Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project

NCT ID: NCT05057156

Last Updated: 2021-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-31

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Epilepsy leads to cognitive impairment in 20-50%. Compared to seizures, these cognitive disorders are a major additional factor in occupational, social and family disability. Memory and language skills are most often impaired. These disorders are well described, multifactorial, but no therapy (drug and/or non-drug) has been validated to date. Recently, cognitive remediation techniques have shown benefits in certain neurological pathologies, such as multiple sclerosis. In adult epilepsy, few previous cognitive remediation studies were performed but suffer significant methodological shortcomings that limit the scope of their results. Studies that have focused on cognitive function have shown promising results for attention and memory. In contrast, in the area of language, no studies have been published.

Objective: to evaluate the effectiveness of a digital solution (PRODDIGE\*) on the lexical access capacities in people with epilepsy.

Method: Randomized, multicentric, observational study which will compare the use of a digital solution (PRODDIGE) in total autonomy versus the supervised use by a trained neuropsychologist. A neuropsychological assessment will be provided before and after a period of 4 months of use of the digital solution.

Material: The medical project aims to offer an application of cognitive remediation to patients who suffer from cognitive impairments and especially language disorders.

T The App is like a serious game, it's based on the playfulness of "game" and the seriousness of "medical exercise". During the exercise the patient can ask for clues help and isn't constrained by time in order to succeed "his mission".

Conclusion: This will be the first French speaking app specifically dedicated to rehabilitation of language deficits observed in people with epilepsy. The expected benefits are an improvement of the patients' language complaints, the regular use of an adapted digital solution to improve their language difficulties, but also a better understanding of their disorders and an improvement of their self-esteem.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

o best help patients, Norsys enterprise designed the app with three key principles:

1. Co-designed, to encourage the emergence of original solutions about uses from patients and therapists,
2. User-friendly, to encourage the patient to exercise regularly and with pleasure (soft, optimistic, pleasant and calm mood),
3. Accessible design, to get an application compatible and adapted to the specifics of these patients (contrast, color, typography, manipulation) According to these principles, the app gives access to 6 mini-games in its first version and will be available on iOS and Android smartphones.

These exercises allow patients to work on specific aspects of their pathologies, this is how the exercises are intended to be playful, dynamic (ex. drag'n'drop) and sometimes collaborative.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Change

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

multicentric, transversal and randomized trial.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"application supervised by a psychologist via teleconsultations"

patient have app, and teleconsultation with psychologist

Group Type EXPERIMENTAL

cognitive rehabilitation

Intervention Type BEHAVIORAL

patients have to use an app with cognitive games

"application in total autonomy"

patients have app, they play when they want

Group Type PLACEBO_COMPARATOR

cognitive rehabilitation

Intervention Type BEHAVIORAL

patients have to use an app with cognitive games

"control" group without using the application

patients haven't app

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cognitive rehabilitation

patients have to use an app with cognitive games

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person with epilepsy, according to Fisher et al. (2005) criteria: all type of epilepsy could be include (new-onset and drug-resistant)
* Treatment must have been stable for 4 months: have the same molecule
* Person who has received full information about the organization of the research and has not objected to his or her participation and the use of his or her data
* Person aged 18 and over
* Mandatory affiliation to a social security scheme
* Validated cognitive inclusion criterion: having a YES response on the cognitive complaint questionnaire :

A.Spontaneous complaint :

Does the patient spontaneously complain of language difficulties?

B.Subjective complaint :

1. Do you search for your words?
2. Do you sometimes feel like you have the word on the tip of your tongue?
3. Do you sometimes have trouble finding the names of people you know well?
4. Do you ever say one word for another?

Exclusion Criteria

* Person with another neurological condition

Patients and normal control :

* A person over the age of majority who is subject to a legal protection measure or who is unable to express their consent.
* Person deprived of liberty by a judicial or administrative decision
* A person who regularly uses psychoactive substances (cannabis, alcohol, etc.).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UCB Pharma

INDUSTRY

Sponsor Role collaborator

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

helene brissart, PhD, HDR

Role: CONTACT

3383851689

louis maillard, Pr

Role: CONTACT

383852377

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02482-37

Identifier Type: REGISTRY

Identifier Source: secondary_id

2020PI095

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neural Basis of Cognition
NCT05132543 NOT_YET_RECRUITING NA